01/17/2025
10:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/03/2025
9:20 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024
7:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024
7:37 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F/A | |
12/10/2024
7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
8:17 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
7:54 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
6:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
8:08 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
10/11/2024
2:25 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024
8:39 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024
7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024
8:13 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
1:40 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
8:04 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
8:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
8:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2024
11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
08/06/2024
4:16 PM | ImmunoPrecise Antibodies (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
07/30/2024
12:57 PM | ImmunoPrecise Antibodies (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/29/2024
7:35 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
07/23/2024
8:55 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024
8:41 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
7:32 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:12 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024
12:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024
1:23 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
12:21 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:19 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2024
9:33 AM | ImmunoPrecise Antibodies (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G | |
02/23/2024
4:26 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
02/23/2024
4:29 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Did You See Trump’s Manhattan Project Bombshell? (Ad) This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House.
Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)...
Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.  Click here and see for yourself. |
02/15/2024
2:12 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
Free IPA Stock Alerts